Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Factor Xa-Segatroxaban
Segatroxaban

Chemical Structure : Segatroxaban

CAS No.: 1184300-63-7

Segatroxaban (SAR107375E)

Catalog No.: PC-24866Not For Human Use, Lab Use Only.

Segatroxaban (SAR107375E) is a potent and highly selective dual FIIa/Xa inhibitor with Ki values of 8 nM and 1 nM on FIIa and FXa, IC50 values of 0.3/0.7 nM (FIIa/FXa) in buffer and of 16/3 nM (FIIa/FXa) in plasma, respectively.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

Segatroxaban (SAR107375E) is a potent and highly selective dual FIIa/Xa inhibitor with Ki values of 8 nM and 1 nM on FIIa and FXa, IC50 values of 0.3/0.7 nM (FIIa/FXa) in buffer and of 16/3 nM (FIIa/FXa) in plasma, respectively.

Physicochemical Properties

M.Wt 568.10
Formula C24H30ClN5O5S2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Thiophenecarboxamide, 5-chloro-N-[(2S)-2-[[[2-methyl-3-(2-oxo-1-pyrrolidinyl)phenyl]sulfonyl]amino]-3-(4-methyl-1-piperazinyl)-3-oxopropyl]-

References

1. Beck H, et al. J Med Chem. 2025 Jun 11. doi: 10.1021/acs.jmedchem.5c00538.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: